论文部分内容阅读
小儿脑梗塞为儿科临床急重症,早期合理、及时、有效地治疗对预后至关重要。近年来由于CT的广泛应用,为小儿脑梗塞的诊断提了方便、准确的检查手段,对以前称之为小儿急性偏瘫综合征的一组疾病,经CT证实多为脑梗塞所致。我院从1999年-2003年4月用路路通(中国吉林东北虎制药有限公司生产)治疗小儿脑梗塞48例,取得了比较满意的疗效,同时运用复方丹参注射液、胞二磷胆碱注射液治疗24例(下称对照组)做疗效对比观察,现报告如下。
Pediatric cerebral infarction is a critical pediatric clinical emergency, early reasonable, timely and effective treatment of the prognosis is crucial. In recent years due to the wide application of CT, pediatric cerebral infarction for diagnosis provides a convenient and accurate means of examination, previously known as pediatric acute hemiplegia syndrome, a group of diseases, mostly confirmed by CT due to cerebral infarction. In our hospital from 1999 - 2003 April with the road pass (Jilin, China Northeast tiger Pharmaceutical Co., Ltd.) treatment of 48 children with cerebral infarction, and achieved satisfactory results, while the use of compound Danshen injection, citicoline Injection treatment of 24 cases (hereinafter referred to as the control group) to do the efficacy comparison, are as follows.